GPhA ANSWERS FDA WORKSHOP QUESTIONS ON BIOGENERICS

Generic Line
A A

In a December 2004 report, the Generic Pharmaceutical Association (GPhA) offered answers to questions that the FDA posed in a September 2004 workshop on the scientific challenges of creating follow-on biologics, or biogenerics.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $10.00